Scpharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $10,026 | $8,054 | $6,102 | $6,096 |
Gross Profit | 6,715 | 5,754 | 4,266 | 4,323 |
EBITDA | -33,250 | -14,904 | -11,956 | -11,580 |
EBIT | -33,163 | -14,956 | -12,007 | -11,720 |
Net Income | -35,105 | -17,090 | -14,108 | -13,812 |
Net Change In Cash | 10,026 | 8,054 | 6,102 | 6,096 |
Free Cash Flow | -17,433 | -20,227 | -17,701 | -15,195 |
Cash | 91,484 | 38,504 | 58,447 | 46,814 |
Basic Shares | 46,558 | 38,984 | 38,952 | 38,786 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $13,593 | $2,063 | $0 | $0 |
Gross Profit | 9,782 | -468 | -438 | -399 |
EBITDA | -46,061 | -33,068 | -25,021 | -29,223 |
EBIT | -46,687 | -33,536 | -25,459 | -29,622 |
Net Income | -54,810 | -37,519 | -30,486 | -34,393 |
Net Change In Cash | 13,593 | 2,063 | 0 | 0 |
Cost of Revenue | -3,207 | 2,449 | -805 | |
Free Cash Flow | -59,284 | -34,598 | -27,160 | -27,693 |
Cash | 46,814 | 71,061 | 74,268 | 105,277 |
Basic Shares | 38,513 | 28,358 | 27,351 | 24,568 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-06-30 | -$0.44 |
2024-03-31 | -$0.36 |
2023-12-31 | -$0.35 |
